188 articles from FRIDAY 29.1.2021

Tort claim could ensure doctors inform women of risk of stillbirth

As part of standard patient protocol, doctors inform women of the risks of pregnancy. But there is one exception to this standard: stillbirth. University of Arkansas law professor Jill Wieber Lens argues that women have a right to know of the risk of stillbirth, and, consistent with the evolution of informed consent law, this right should be enforceable through a medical malpractice tort claim.

Turning on the switch for plasticity in the human brain

Shigeki Watanabe and colleagues describe how glutamate signals are transmitted across synapses to turn on the switch for synapatic plasticity, the ability of synapses to strengthen or weaken over time in response to increases or decreases in their activity.

Two ADAURA analyses support use of Osimertinib for patients with surgically resected, Stage IB to IIIA non-small cell lung cancer

Two presentations from the ADAURA clinical trial advanced previous research that demonstrated improved disease-fee survival (DFS) outcomes for patients with surgically resected non-small cell lung cancer (NSCLC) receiving osimertinib. The data were reported today at the International Association for the Study of Lung Cancer's 2020 World Conference on Lung Cancer (WCLC) Singapore.

Women who develop high blood pressure after birth at greater risk of chronic hypertension

In a new study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting™, researchers from the University of Pittsburgh will unveil findings that suggest that women who develop high blood pressure during pregnancy and who continue to have elevated blood pressure postpartum are at an increased risk for developing chronic hypertension.

'Dodged a bullet': Melbourne lockdown may have prevented more deadly Covid-19 variant

Researchers say the variant that swept Victoria during last year’s second wave was mutating into something more worryingA variant of Covid-19 similar to the one that spread rampantly in the UK would likely have developed in Victoria during last year’s second wave had Melbourne not gone into an extended lockdown, a leading virologist says.Associate Professor Stuart Turville from the Kirby...

Novavax Covid vaccine shown to be nearly 90% effective in UK trial

UK vaccines taskforce has bought 60m doses after study found ‘spectacular results’Coronavirus – latest updatesSee all our coronavirus coverageAnother vaccine against Covid, trialled in the UK and bought by the government, has been shown to be nearly 90% effective and work against the UK and South African variants of the virus.The UK vaccines taskforce has bought 60m doses of the Novavax...